PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study reveals two distinct genetic subtypes in colon adenocarcinoma (COAD) linked to PANoptosis and immune activity. A new prognostic model using these factors predicts survival, aiding personalized COAD treatment.
Area Of Science
- Immunology
- Oncology
- Cell Biology
Background
- PANoptosis, a novel cell death pathway, is linked to immune responses but its role in tumors remains unclear.
- Understanding PANoptosis mechanisms and regulation in cancer is crucial for developing new therapeutic strategies.
- This study focuses on colon adenocarcinoma (COAD), investigating the prognostic significance of PANoptosis-related genes.
Purpose Of The Study
- To explore the prognostic value of PANoptosis-related genes in colon adenocarcinoma (COAD).
- To identify genetic subtypes of COAD based on PANoptosis pathways and immune gene expression.
- To develop a prognostic model for COAD survival outcomes.
Main Methods
- Utilized The Cancer Genome Atlas-COAD (TCGA-COAD) dataset (458 cases).
- Analyzed five PANoptosis pathways and immune-related genes.
- Identified genetic subtypes and developed a prognostic model.
Main Results
- Discovered two distinct genetic subtypes in COAD with differential PANoptosis and immune gene expression.
- Developed a prognostic model demonstrating significant predictive power for survival.
- Highlighted the interplay between PANoptosis and immune responses in COAD progression.
Conclusions
- The study enhances understanding of COAD's genetic landscape, emphasizing the link between cell death and immunity.
- A novel prognostic model offers potential for personalized treatment strategies in COAD.
- Further clinical validation is recommended to refine the model for therapeutic applications.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...